Concepedia

David Ungar

DU

18

Publications

1.2K

Citations

15

H-Index

1992

Active since

Affiliations

University College London(Current)

University of Michigan

University College London Hospitals NHS Foundation Trust

Washington University in St. Louis

Medical College of Wisconsin

David Ungar is an author at University College London specializing in medicine, immunology, and immunotherapy.

Top concepts

Publications per year

1992–2021

18

Publications

18

Loncastuximab tesirine in relapsed or refractory diffuse large B-cell lymphoma (LOTIS-2): a multicentre, open-label, single-arm, phase 2 trial

Paolo F. Caimi, Weiyun Z. Ai, Juan Pablo Alderuccio et al. · The Lancet Oncology · 2021 · 397 citations

, , +6

Final results of a phase 1 study of loncastuximab tesirine in relapsed/refractory B-cell non-Hodgkin lymphoma

Mehdi Hamadani, John Radford, Carmelo Carlo‐Stella et al. · Blood · 2020 · 165 citations · Full text

A Phase I Study of ADCT-402 (Loncastuximab Tesirine), a Novel Pyrrolobenzodiazepine-Based Antibody–Drug Conjugate, in Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma

Brad S. Kahl, Mehdi Hamadani, John Radford et al. · Clinical Cancer Research · 2019 · 102 citations

Neoplasms in a pediatric population: 2-[F-18]-fluoro-2-deoxy-D-glucose PET studies.

Barry L. Shulkin, Deanna Mitchell, David Ungar et al. · Radiology · 1995 · 98 citations

Children are not small adults: Documentation of assent for research involving children

David Ungar, Steven Joffe, Eric Kodish · The Journal of Pediatrics · 2006 · 83 citations

, , +13

Rows per page

1–5 of 18